Growth leadership Executive leadership transitions and recent hires indicate a shift toward scale and enterprise sales focus, presenting an opportunity to engage the new CEO and EVP of Sales with strategic partnerships and large-scale outcomes initiatives.

Strategic partnerships Recent collaboration with MD Hyperbaric to pilot HBOT outcome evaluations signals openness to joint programs and data partnerships; target analogous specialty providers and therapy networks for expanded real-world evidence collaborations.

Clinical network Growing network of contributing providers and millions of data points Suggests strong value proposition for health systems and medical device firms seeking real-world evidence; approach larger hospitals and device manufacturers with scalable data integration opportunities.

Regulatory readiness Position as an unbiased healthcare outcomes authority aligns with market trends toward evidence-based regulation and payer transparency; engage with product developers and payer-focused teams on outcomes dashboards and compliance-ready analytics.

Market traction finalist status in the 2024 Arizona Innovation Challenge and a clear path toward expanded leadership indicate momentum; leverage these milestones to accelerate outreach to regional health systems and early-adopter customers seeking differentiated ROI.